A property holding, a Chapter 18A biotech position, and a long-listed financial-institution stake share the same legal framework but require materially different transaction structures. Sector is not decorative. It is the second-most-important structural variable after position quality itself.
Across the HKEX issuer universe, the same instrument — a share-backed loan — behaves materially differently depending on the sector of the underlying. The legal framework is uniform; the operational and risk profiles are not. The arranger who applies a generic structure across sectors produces transactions that work in benign conditions and break in adverse ones.
Property and REIT holdings sit at one extreme. Cash flows are relatively stable; liquidity in the underlying shares is typically deep for the larger names; controlling-shareholder concentration is common, with multi-generational family holdings dominant. Loan-to-value ratios can be relatively high for the largest property names with sufficient float. The structuring considerations specific to property are dividend-cycle alignment (REIT distributions are predictable and often material), and sometimes a specific overlay where the underlying entity itself is structured through complex inter-company arrangements.
Financials and insurance sit at the opposite end of the regulatory-sensitivity spectrum. Cross-holdings are common; specific SFC sectoral oversight applies to certain holdings; banks themselves are constrained in how they can serve as lenders or custodians for share-backed transactions against other financial-sector positions. For a director of a Hong Kong-listed bank pledging shares of their own institution, the disclosure analysis is involved and the choice of lender carries a reputational dimension. Loan-to-value ratios are typically moderated by the regulatory weight of the underlying.
Technology and internet, including the increasingly important mainland China tech with HK secondary listings, presents a different profile again. Founder concentrations are typical; volatility is elevated relative to property or financials; some positions carry weighted-voting-rights (WVR) structures with their own implications for pledge mechanics. The arranger structures these transactions with shorter tenors, more conservative LTVs, and explicit attention to corporate-action risk.
Chapter 18A pre-revenue biotech is the most specialised case. The underlying issuer typically has no revenue; valuation is research-pipeline-driven and event-sensitive; FDA, NMPA, and equivalent regulatory milestones can move the share price by large multiples in either direction in a single session. LTVs are materially lower than for any other sector — often half of what a comparable position size in financials or property might support. Tenors are shorter. The custody arrangement frequently includes specific provisions for sudden price moves. The arranger who treats a Chapter 18A position the way they treat a long-listed property name has not understood the instrument.
Consumer, retail, healthcare, energy, industrials, and the conglomerate-holding-company structures common in Hong Kong each have their own structural specifics, but the same principle obtains: the sector defines what is structurally appropriate. Generic stock loans, marketed without sectoral specialisation, are the products of arrangers who have not done the work — and over the full cycle, they are the products that produce the cases the rest of the industry has to work around.
Stock loans are not commodity products. They look superficially identical across sectors; their internals are anything but. The transaction that lands smoothly is the one structured against the specific dynamics of the underlying name.
Edward Chan Wai-Lun, Founder & Managing Principal